Pathological complete response and survival after neoadjuvant chemotherapy in patients with stage I TNBC: a registry-based study
Data from this real-world nationwide Dutch registry on neoadjuvant chemotherapy for stage I TNBC, with the majority of patients having cT1cN0 disease of no special subtype, suggests pCR to be associated with a favorable long-term outcome.
Authors
- M. de Graaf (ORCID: https://orcid.org/0009-0008-3598-3293)
- M. Kok
- Sara Balduzzi (ORCID: https://orcid.org/0000-0003-1205-1895)
- Sabine C. Linn (ORCID: https://orcid.org/0000-0001-5541-0347)
- Sabine Siesling (ORCID: https://orcid.org/0000-0002-0273-824X)
- R. Gielen
Institutions
- The Netherlands Cancer Institute (NL)
- Oncode Institute (NL)
- Netherlands Comprehensive Cancer Organisation (NL)
Publication Details
- Journal
- ESMO Open
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.esmoop.2025.105923
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Association for Cancer Research
- Global Fund for Women
- Pelotonia
- Ministerie van Volksgezondheid, Welzijn en Sport
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek